Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Possible mechanism by which vitamin E reduces the risk of prostate cancer

June 25, 2002

Tanox outlicenses Bak gene

June 21, 2002

MMP-targeting NeuGene antisense agent inhibits prostate cancer growth

June 21, 2002

Sankyo patents new antitumor compounds

June 20, 2002

CoFactor phase II trial design finalized

June 20, 2002

Biological activity of paclitaxel-glucose conjugate tested in human cancer cell lines

June 20, 2002

Abbott identifies aryl tetrahydropyridine farnesyltransferase inhibitors

June 20, 2002

131I-TM-601 to enter phase I/II for glioma

June 19, 2002

Lorus and NCI collaborate on GTI-2040 phase II program

June 19, 2002

AxCell enters into CRADA with NCI to research TEY1 for prostate cancer

June 19, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...